A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation

Guohui Wan1, Xiaoxiao Hu, Yunhua Liu

  • 1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

The EMBO Journal
|October 8, 2013
PubMed

Insights

A novel long non-coding RNA, lncRNA-JADE, is activated by DNA damage and promotes breast tumor growth by enhancing histone acetylation. Its dysregulation may drive tumorigenesis, offering a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • DNA damage response (DDR) is crucial for preventing cancer.
  • Long non-coding RNAs (lncRNAs) are emerging regulators in cellular processes.
  • The role of lncRNAs in DDR and tumorigenesis is under investigation.

Purpose of the Study:

  • To identify novel lncRNAs involved in the DNA damage response.
  • To elucidate the function of lncRNA-JADE in DNA damage and breast cancer.
  • To investigate the mechanism by which lncRNA-JADE influences gene expression.

Main Methods:

  • Identification of lncRNA-JADE via DNA damage induction.
  • Analysis of lncRNA-JADE's dependence on ATM signaling.
  • Assessment of lncRNA-JADE's effect on Jade1 and histone H4 acetylation.
  • Evaluation of lncRNA-JADE expression in human breast tumors.
  • In vivo studies using lncRNA-JADE knockdown in mouse models.

Main Results:

  • A novel lncRNA, lncRNA-JADE, was identified and found to be induced by DNA damage in an ATM-dependent manner.
  • lncRNA-JADE transcriptionally activates Jade1, leading to increased histone H4 acetylation.
  • Elevated lncRNA-JADE levels were detected in human breast tumors compared to normal tissues.
  • Knockdown of lncRNA-JADE significantly suppressed breast tumor growth in vivo.

Conclusions:

  • lncRNA-JADE acts as a critical link between the DNA damage response and histone acetylation.
  • Dysregulation of lncRNA-JADE contributes to breast tumorigenesis.
  • lncRNA-JADE represents a potential diagnostic marker and therapeutic target for breast cancer.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Base-pairing and DNA Repair02:27

Base-pairing and DNA Repair

Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,